Immune-Enhancing Effects of Limosilactobacillus fermentum in BALB/c Mice Immunosuppressed by Cyclophosphamide
Nutrients · 2023
DOI: 10.3390/nu15041038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von SukJin Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bio-Health Convergence Major, Duksung Women's University, Seoul 01369, Republic of Korea. Hauptthemen laut MEDLINE: Limosilactobacillus fermentum, Probiotics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, TIPA, Korean ministry of education.
Abstract (Originalsprache)
This study evaluates the immune-enhancing effects of Limosilactobacillus fermentum on cyclophosphamide (CP)-induced immunosuppression in BALB/c mice. In vitro, the expressions of pro-inflammatory cytokines and MAPK signaling molecules in Raw264.7 cells were analyzed by ELISA and Western blot analysis. Moreover, cell proliferation, surface receptor expression, and cytotoxicity of NK-92 cells were examined by Cell Counting Kit-8, CytoTox96 assay, and flow cytometry, respectively. To investigate the immune-enhancing effects of selected L. fermentum strains in vivo, these strains were orally administered to BALB/c mice for 2 weeks, and CP was intraperitoneally injected. Then, liver, spleen, and whole blood were isolated from each animal. Administration of single L. fermentum strains or their mixture sustained the spleen weight, the counts of white blood cells compared to non-fed group. Splenocyte proliferation and NK cytotoxicity were significantly increased in all L. fermentum-fed groups. The frequency of B220+ cells was also significantly enhanced in splenocytes isolated from L. fermentum groups. In addition, the production of cytokines (TNF-α, IFN-γ) and antibodies was recovered in splenocyte supernatants isolated from L. fermentum groups. In conclusion, L. fermentum could be a suitable functional food additive for immune-enhancing effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bio-Health Convergence Major, Duksung Women's University, Seoul 01369, Republic of Korea.
- Department of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea.
- Duksung Innovative Drug Center, Duksung Women's University, Seoul 01369, Republic of Korea.
- Mediogen, Co., Ltd., Bio Valley 1-Ro, Jecheon-si 27159, Republic of Korea.
- College of Pharmacy, Vessel-Organ Interaction Research Center, VOICE (MRC), Cancer Research Institute, Kyungpook National University, Daegu 41566, Republic of Korea.
ORCID-Profile: SukJin Kim, Hwan Hee Lee, Chang-Ho Kang, Hyojeung Kang, Hyosun Cho
Förderung
- National Research Foundation of Korea
- TIPA
- Korean ministry of education
Zitieren
APA
Kim, S., Lee, H. H., Kang, C. H., Kang, H., & Cho, H. (2023). Immune-Enhancing Effects of Limosilactobacillus fermentum in BALB/c Mice Immunosuppressed by Cyclophosphamide. Nutrients. https://doi.org/10.3390/nu15041038
Vancouver
Kim S, Lee HH, Kang CH, Kang H, Cho H. Immune-Enhancing Effects of Limosilactobacillus fermentum in BALB/c Mice Immunosuppressed by Cyclophosphamide. Nutrients. 2023. doi:10.3390/nu15041038
BibTeX
@article{Kim2023,
author = {Kim, SukJin and Lee, Hwan Hee and Kang, Chang-Ho and Kang, Hyojeung and Cho, Hyosun},
title = {Immune-Enhancing Effects of Limosilactobacillus fermentum in BALB/c Mice Immunosuppressed by Cyclophosphamide},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15041038}
}
EUVIMED